Medexprim has welcomed Thomas Josse as Customer Success Director to reinforce its Delivery and Support teams. Thomas will be responsible for the smooth running of service activities and customer satisfaction on the missions he will supervise.
Fabrice Pillon, General Manager of Customer Success: “We want to offer all our customers and partners access to excellent quality datasets with a high level of service. To achieve this goal, we will continue our efforts to industrialize our deployment processes and work with the team to continuously improve the project methodology. Thomas, with whom I have worked for several years, will be an invaluable asset”.
Thomas Josse, about his appointment: “I am very happy to join Medexprim and to contribute to a mission that makes sense to me. I would like to participate in the development of the Delivery team and offer our clients solutions adapted to the challenges of clinical research. Medexprim has many expertises, and we will all work together to accelerate innovations in healthcare! “
Passionate about new technologies and digital innovation, Thomas has 15 years of experience in account management and deployment of hospital information systems (HIS) in healthcare institutions, in France and Europe.
REAL-WORLD EVIDENCE FOR BETTER CARE
Medexprim is Europe’s leading provider of secure imaging and clinical data extraction to accelerate medical research. As a real-world data specialist, we build bridges between leading academic hospitals and pharmaceutical, AI and medical device companies. In compliance with the GDPR, we help hospitals drive their own clinical research strategy and extract value from their data, through our software and services designed with and for clinicians. We provide our partners with secure access to regulatory-grade data. Medexprim aims to build multicentric disease-specific data lakes to serve oncology, neurology and cardiology. We help solve the “one patient, one disease, one treatment” equation to develop precision medicine for better care.
Medexprim Press contact: Anne-Sophie Labeta